| Current Price | $0.26 | Mkt Cap | $33.4M |
|---|---|---|---|
| Open | $0.27 | P/E Ratio | 0.00 |
| Prev. Close | $0.26 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $0.26 - $0.27 | Volume | 323,399 |
| 52-Wk Range | $0.19 - $0.51 | Avg. Daily Vol. | 672,086 |
| Current Price | $0.26 | Mkt Cap | $33.4M |
|---|---|---|---|
| Open | $0.27 | P/E Ratio | 0.00 |
| Prev. Close | $0.26 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $0.26 - $0.27 | Volume | 323,399 |
| 52-Wk Range | $0.19 - $0.51 | Avg. Daily Vol. | 672,086 |
The best Bull and Bear pitches based on recency and number of recommendations.
5 years might even be too short of a timeframe to judge this company, but I want "in on the ground floor." Thumbs up.
I've spent several hours reading the short reports and the hype articles. This company, formerly known as Real Estate Restoration and Rental Inc., just doesn't smell right. I encourage you to dig into the SEC filings or watch one of the company's… More
Read the most recent pitches from players about ONVO.
Recs
TheLibrarian
(90.52)
Submitted: 4/14/2016 1:29:05 AM :
Start Price:
$2.52
NASDAQ:ONVO Score:
-108.78
Whereas 3D printing in itself offers great investment opportunity for the next 10 years, Organovo plans to use the technology to print lifelike human organs for drug testing purposes, and eventually use organs for transplantation. Naysayers often remark that the technology is too young and any investment at this point would be too early, but the technology is coming, and this opportunity won't be available at this price forever.
Recs
StockGambler
(< 20)
Submitted: 1/23/2016 3:47:34 PM :
Start Price:
$2.01
NASDAQ:ONVO Score:
-117.52
Organovo Holdings does 3-D printing of live tissue. Currently liver tissue, with kidney tissue in the pipeline. Bioprinted living tissue can greatly reduce testing expenses for big pharma. Their are major advantages over using rats or mice, or removing tissue for testing. While other 3-D processes have fallen out of favor, this process holds great promise. See the director of R&D Tissue Applications discuss the process on their website
http://www.organovo.com/deb-nguyen-12-2013-podcast
This podcast is quite informative,
Recs
gtechie
(79.87)
Submitted: 5/20/2015 9:46:17 AM :
Start Price:
$4.58
NASDAQ:ONVO Score:
-110.89
5 years might even be too short of a timeframe to judge this company, but I want "in on the ground floor." Thumbs up.
Find the members with the highest scoring picks in ONVO.
MAKmeMONEY (93.48) Score: +333.02
The Score Leader is the player with the highest score across all their picks in ONVO.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| bluebare | 32.45 | 11/13/2012 |
|
5Y | $2.31 | -88.56% | +80.01% | +168.58 | 0 Comment | |
| Retirefunds | < 20 | 8/17/2012 |
|
5Y | $2.16 | -87.77% | +74.80% | +162.57 | 0 Comment | |
| tortoisetriguy | 74.65 | 1/22/2013 |
|
3M | $4.90 | -94.60% | +67.30% | +161.90 | 0 Comment | |
| macvel | 62.70 | 5/6/2013 |
|
5Y | $4.30 | -93.86% | +53.66% | +147.52 | 0 Comment | |
| comsecga | 45.12 | 5/10/2013 |
|
NS | $4.45 | -94.06% | +52.25% | +146.31 | 0 Comment | |
| DarielFool | 49.69 | 7/16/2013 |
|
3M | $6.68 | -96.05% | +48.07% | +144.12 | 0 Comment | |
|
pigsfeet007 | 86.21 | 10/7/2013 |
|
5Y | $5.90 | -95.52% | +48.22% | +143.74 | 3 Comments |
| Quaker08 | 25.75 | 8/15/2013 |
|
5Y | $5.74 | -95.40% | +48.23% | +143.63 | 0 Comment | |
| zman4money | 23.39 | 5/16/2013 |
|
5Y | $4.20 | -93.71% | +49.69% | +143.40 | 0 Comment | |
| lorteungen | 99.41 | 8/13/2013 |
|
5Y | $5.66 | -95.33% | +46.48% | +141.81 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
